Epidemiology and Clinical Characteristics of Human Metapneumovirus Infections in Hospitalized Children in Two Consecutive Postpandemic Years

Ruth Steinberg,Véronique Marty,Insa Korten,Christoph Aebi,Philipp Latzin,Philipp KA Agyeman
DOI: https://doi.org/10.1097/inf.0000000000004221
2024-03-09
The Pediatric Infectious Disease Journal
Abstract:Human metapneumovirus (HMPV) was first described 20 years ago and is a common cause of upper and lower respiratory tract infections in infants and children. 1 Most children with HMPV infection develop a mild upper respiratory tract infection; however, more severe clinical courses, including life-threatening severe bronchiolitis and pneumonia, are possible. 1 Globally, HMPV is detected in approximately 3%–10% of hospitalizations of younger children (<5 years of age) with acute lower respiratory tract infections. 1 Symptomatic treatment varies depending on the clinical course but may include intensive care unit (ICU) treatment and mechanical ventilation in severe cases. 2 In the Northern Hemisphere, HMPV infections typically peak in March, with seasonal occurrence from late winter to spring (January–March). 3
pediatrics,immunology,infectious diseases
What problem does this paper attempt to address?